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Summary
The aim of this study was to explore whether Thy-1, like other members ofthe Ig-like superfamily
(e.g., CD2 and neural cell adhesion molecule), participates in cell-cell adhesion. This was investigated
by measuring the binding of Thy-1+ probe cells (thymocytes or AKR1 T lymphoma cells) to
Thy-1 - cloned mouse thymic epithelial (MTE) cells using a quantitative cell adhesion assay . The
results were as follows : (a) the thymo-epithelial cell interaction was found to be inhibitable (by
25-40%) by soluble Thy-1 molecules purified from phosphatidylinositol-specific phospholipase
C-treated mouse thymocytes as well as by Fab' fragments ofa Thy-1-specificmAb ; (b) the binding
of the Thy-1 - AKR1 (Thy-1 -d) mutant to MTE cells was found to be reduced (by 50%) as
compared with that of the wild type T lymphoma; (c) the Thy-1-mediated adhesion pathway
did not require Caz+ and promoted the initial thymo-epithelial binding measured at 4°C. These
data provide the first direct evidence of an adhesive function of Thy-1 and suggest that this molecule,
in addition to its T cell triggering properties, might play a role during the earlyT cell maturation
by promoting thymocyte adhesion to thymic stroma .
T
hy-1 is a glycoprotein abundantly expressed by neurons
and murine thymocytes (1) . It is composed of an IgV
domain-like polypeptide of 112 amino acids which is anchored
in the plasma membrane through a glycosyl-phosphatidyl-
inositol (G-PI) tail (2) . Although the Thy-1 gene appears to
be extremely conserved during evolution, its pattern of ex-
pression, while under strict tissue-specific control, does vary
to some extent between species (3) . Thus, Thy-1 becomes
a major neuronal surface protein in rodents several weeks after
birth, whereas its expression on thymocytes reaches a max-
imum level around day 15 of gestation, i.e., immediately after
the entry of prothymocytes into the thymus ; Thy-1 surface
expression decreases significantly when mouse thymocytes
migrate to the periphery and is absent from rat peripheral
T cells (3) . Despite these studies on Thy-1 structure, expres-
sion, and gene organization, the physiological role of this
molecule has remained a matter of speculation . Thy-1, like
several other G-PI-anchored surface molecules, has been im-
plicated in T cell activation (4) .
There is increasing evidence that members of the Ig-like
superfamily (e.g., neural cell adhesion molecule [NCAM],
CD2, and lymphocyte function-associated antigen 3 [LFA-
3]), participate in cell adhesion (2, 5) . The fact that thymo-
cytes upregulate Thy-1 surface expression while maturing in
the vicinity of the thymic stroma led us to explore the possi-
bility that this molecule could participate in lympho-epithelial
cell interactions . Use of normal thymocytes andTlymphoma
cells rather than transfected cells was chosen to evaluate this
issue. However, the likely participation of other adhesion
systems such as CD2/LFA3, LFA1/intercellular adhesion
molecule 1 (ICAM-1), CD8/MHC class I molecules shown
by us and others (6-8) to play a role in these cell interactions
required the use of a quantitative cell adhesion assay initially
described by McClay et al . (9) . We report here experimental
evidence that Thy-1 is involved in lympho-epithelial cell
adhesion through a heterophilic and Ca2+ -independent
mechanism .
Materials and Methods
mAbs.
￿
The ratmAbs H155-124 (y2CK) , H154-200 (y2b,u), and
H140-150 (y2b,ic) recognize monomorphic Thy-1 determinants in
the epitope regions C and B, respectively ; 5A2 is a rat yl,rc anti-
mouseI1r2R antibody; H129-296 is a rat y2a,a mAb defining the
epitope CofmouseLFA-1 heavy chain ; H35-17 is a rat y2b,umAb
to mouse CD8; YNI is a rat anti-mouse ICAM-1 . The origin and
specificity of these mAbs have been described elsewhere (8, 10) .
Cells.
￿
Viable thymocytes were obtained from neonatal Swiss
mice by centrifugation on a Ficoll (Pharmacia, Uppsala, Sweden)
Telebrix 38 (Guerbet, Paris, France) gradient .Thewild-type (AKR1)
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were provided byR. Hyman(The Salk Institute, SanDiego, CA) .
Cell Adhesion Assay . The cell adhesion assaywas modified (8)
from that described by McClay et al . (9) . In brief, MTE cell
monolayers were grown to confluency in type I collagen-coated
(Sigma Chemical Co ., La verpilliere, France), flat-bottomed, 96-
well flexible plates (Dynatech Laboratories, Marnes-La-Coquette,
France) for 48 h . Probe cells were labeled with "Cr (25 1ACi/ml
in complete culture medium for3 h at 37°C) . Cells were washed
(x2) andresuspended in culture medium containing 5mMEDTA
when appropriate . Labeled thymocytes (101) or T lymphoma cells
(5 x 10') were added to each well of the plates containing the
MTE cells and spun onto the monolayer at 50 g for 3 min at 4°C.
The wellswere filled with medium up to the rim and sealed with
plastic sheets . The plates were immediately inverted and centrifuged
upsidedown for 5 min. Theoptimal radial centrifugal force(RCF)
for the detectionof the Thy-1-dependent cell adhesion was evalu-
ated to be between 100 and 200g. In all but one (shown in Fig.
4) experiment, a force of 100g wasused. Plates were quickly frozen,
and theirbottom 3mm were cut offandcounted . Thepercentage
of binding was defined as the ratio between the bound cpm and
the totalcpminput. Results were expressed as the arithmeticalmean
of quadruplicate measurements; standard errors were generally
<5%. mAb-mediated inhibition of cell adhesion was assayed by
preincubating radiolabeled probe cells with Fab! fragments for 30
min at 4°C. In some experiments, purified Thy-1, or the superna-
tants containing glypiated molecules, were preincubated withMTE
cell monolayer for 2 h at 4°C . In both cases, cells were washed
at 4°C before the adhesion assay.
Solubilization, ImmunodepletionandPurification ofThy-1 Molecules.
Glypiated cell-surface molecules were solubilizedby treating thymo-
cytes with Bacillus thurigensis PI-PLC (0 .1 U/ml in DMEM) (pro-
videdby G. Rougon, CNRS,URA 179, Marseille) . The enzyme
was removed from supernatants by immunodepletion using PI-
PLC-specific rabbit Ig (preparedbyG. Rougon) . For antigen deple-
tion, solubilized molecules were incubated overnight at 4°Cwith
Thy-1 (H155-124)- orIL2R (5A2)-specificmAbcoupled to Seph-
arose-4B (Pharmacia) . Purification of Thy-1 mAb was performed
by applying the PI-PLC-solubilized molecules to an antiThy-1
(H155-124) affinity column as described (2) .
Analysis of Thy-1 Cell Surface Expression .
￿
Membrane proteins
from thymocytes of 2-5-d-oldmice or MTE cells were labeled with
sulfo-NHS-biotin (Pierce Europe RV ., Oud-Beijerland, The Nether-
lands) (11) and subjected to immunoprecipitation .
Results and Discussion
The role played by Thy-1 in the lympho-epithelial cell in-
teractions was demonstrated by studying mouse thymocyte
binding to MTE cell monolayers using the adhesion assay
described above. Microscopic analysis of lympho-epithelial
cell interaction showed that MTE cells grew as a tight
monolayer and that thymocytes were homogeneously and
strongly bound to the cells (8) . No Thy-1 expression could
be detected onMTE cells, either by immunoprecipitation (see
Fig. 1 A) or by a sensitive surface radioimmunoassay (data
not shown) with two distinct Thy-1 epitope-specific mAbs.
In contrast, PI-PLC-solubilized, immunopurified Thy-1 mol-
ecules (Fig. 1 B), which were shown to retain their im-
munoreactivity, were found to bind to MTE cell monolayer
(data not shown) . Preincubation of purified Thy-1 molecules
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Figure 1.
￿
Thy-1 expression on mouse neonatal thymocytes and MTE
cells. (A) Mouse thymocytes and MTE cells were biotinylated and lysed
in Triton X-100. Labeled proteins from MTE cells (lanes a-d) and from
thymocytes (lanes e andf) were immunoprecipitated by either the Thy-
1-specific mAb H154-200 (lanes a and e) or H140-150 (lanes b andJ) .
In the case ofMTE cell detergent extracts, theYN-1 (anti-ICAM-1, lane
d) andH35-17 (anti-CD8, lanec) mAbs were used as positive and negative
controls, respectively. Immune complexes were separated by SDS-PAGE
and transferred to nitrocellulose sheets. Biotinylated proteins were visual-
ized with 1251-labeled streptavidin and radioautography. The positions of
the mol wt standards [Mr (x10-3)] are indicated . (B) Purification of a
hydrophilic form of the Thy-1 molecules from mouse neonatal thymo-
cytes. Cells (5 x 109) were treated with PI-PLC (0.1 U/ml) for 2 h at
37°C. The solubilized Thy-1 molecules were purified from the supema-
tant by affinitychromatography on anantiThy-1mAbcolumn. The purified
molecules were iodinated, subjected to SDS-PAGE and radioautography.
withMTE cells reduced (by25%) thymocyte binding to the
monolayers (Fig . 2A) . To further establish the Thy-l-specific
inhibition ofcell-cell adhesion, supernatants ofPI-PLC-treated
thymocytes (from which PI-PLC had been previously depleted)
were tested for inhibition of cell adhesion before or after
removal of soluble Thy-1 molecules. The results shown in
Fig. 2B support the notion that Thy-1 accounts for most
of the inhibiting capacity of the supernatant . Finally, prein-
cubation ofthymocytes with Fab' fragments ofa Thy-1-specific
mAb (H140-150) specifically reduced thymocyte binding to
MTE cells (with a plateau of 25% inhibition reached at a
concentration of 30 Pg/ml). No inhibition was observed with
the isotype-matched mAb H129-296 which recognized the
LFA1 epitopeC (nonfunctional under the conditions of ini-
tial binding at 4°C) (8) .
The lack of complete inhibition of the lympho-epithelial
cell interaction by purified Thy-1 molecules was not surprising.
First, the thymocytes were heterogeneous, and Thy-1 might
only be involved in the binding of a thymocyte subpopula-
tion to MTE cells. Second, other molecular interactions such
as CD2/LFA-3, LFA1/ICAM are likely to participe in the
cell adhesion (6-8) . To optimize the detection of the Thy-
1-mediated adhesion, we used theAKR1 mouseT lymphoma
(which expresses similar amounts of surface Thy-1 as neo-
natal Swiss thymocytes) and its Thy-1 - variant AKRl(Thy-
1 - d), in which the loss of Thy-1 expression was previouslyFigure 2 .
￿
Thy-1 is involved in mouse thymocyte binding to MTE cell
monolayer. (A) Purified Thy-1 molecules inhibit thymo-epithelial cell in-
teractions. MTE cell monolayers were preincubated for 2 h at 4°C with
different concentrations of purified Thy-1 or BSA (control) and washed
with cold medium before running the adhesion assay (see Materials and
Methods). Control binding (11,504 ± 485 cpm) represents 54.9% ofcell
input . (B) Removal ofThy-1 from PI-PLC-solubilized thymocyte surface
molecules reverses their capacity to inhibit thymocyte binding to MTE
cell monolayer. Preincubation ofMTE cell monolayers with solubilized
glypiated molecules reduced their ability to bind thymocytes ; this inhibi-
tion was no longer observed after depletion of the Thy-1 molecules but
not of the IIr2R molecules from the supernatant . Control binding was
16,098 ± 391 cpm. (C Fab' fragments ofThy-l-specificmAb (H140-150)
inhibit thymo-epithelial cell interaction. SICr-labeled thymocytes were
pretreated with Fab' fragments of Thy-1 (H140-150)- or LFA-1C
(H129-296)-specific mAb for 1 h at 4°C before running the adhesion assay.
Control binding was 9,687 ± 405 cpm .
shown to result from a subchromosomal deletion encom-
passing the Thy-1 gene (12) . Results summarized in Fig . 3
A indicate that under nonsaturating conditions (i .e., <101 thy-
mocytes per assay), the Thy-1 - variant exhibited a binding
level reduced by 50% as compared with the wild-type pa-
rental cells . In contrast, both T lymphoma cell lines bound
with a similar efficiency to the epithelialMDCK cells (8.6%
for AKR1 and 10.3% for AKR1 [Thy-1 -d], respectively) .
We next evaluated the Thy-l-dependent adhesion ofAKR1
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Figure 3.
￿
Thy-1 mediates adhesion between the AKRI T lymphoma
and MTE cells . (A) Binding of various numbers of AKRI cells (0) or
ofits Thy-1 - variant AKRI(Th)l -d) (A) to MTE cell monolayer. Con-
trol binding values were in the range of 1,600-43,000 cpm depending on
the cell input . (B) AKRI binding toMTE cells in the absence ofdivalent
cations . AKRI (p) and AKRI(Thy-1 -d) T lymphoma cells (A) were
pretreated with or without various concentrations of Fab' fragments of
Thy-1-specificmAb (H140-150) for 1 h at 4°C before the adhesion assay,
which was performed in the presence of 5 mM EDTA. Control binding
values were 11,772 t 589 cpm, and 1,801 ± 126 cpm for AKRI and
AKRl(Thy-1 - d), respectively.
in the presence of EDTA . Divalent cations (i .e ., Ca2+ and
Mgt') are known to influence the adhesiveness of cell adhe-
sion molecules such as the integrin and cadherin (13) systems .
In contrast, the adhesion processes depending uponmembers
of the Ig-like superfamily generally appear to be Ca 2+ inde-
pendent . In the absence of divalent cations, the binding of
AKRI to MTE cells was found to be sixfold higher than
that of the AKRI(Tky-1 -d) mutant cells and to be totally
inhibitable in a dose-dependent manner by H140-150 Fab'
fragments (Fig. 3 B) . Under such experimental conditions,
the Thy-l-mediated adhesion appeared predominant in the
AKRl-MTE cell interaction . These results indicated that the
Thy-1-dependent adhesion was Ca2+ independent .
Cell adhesion can be operationally divided into an initial
contact followed by a subsequent enhancement of the inter-
action through energy-dependent processes (5, 14) . The quan-
titative cell adhesion assay used in this study permits the mea-
surements of both the initial binding and the enhancement
(8, 14) . In a previous report (8), aLFA1-dependent enhance-
ment ofthe thymocyte-MTE cell adhesion was observed after
15-30 min incubation at 37°C . By performing the assay at
4°C and detaching the probe cells immediately after their
AKR1
AKR1 (Thy-1-d)
Figure 4 .
￿
Thy-1 is involved in the
initial bindingofthymocytes toMTE
cells. Thymocytes were pretreated
with (A) or without (p) Fab' frag-
ments of the Thy-l-specific mAb
H140-150 (30laglml) and spun onto
the MTE cell monolayers at 4°C .
Plates were then incubated at 37°C
for various periods of time, inverted
and centrifuged again at 4°C (200g,
5 min) . No Fab' fragments were dis-
sociated from the thymocytes during
the 37°C incubation steps (data not
20 4o
￿
so
￿
shown) . Control binding value (at
Time (min)
￿
time 0) was 8,432 ± 317 cpm .initial contact with the MTE cell monolayer, evidence was
obtained that Thy-1 was involved in the initial binding . To
determine whether this molecule was also involved in the
enhancement of the thymo-epithelial cell adhesion, s 1Cr-
labeled thymocytes were detached fromMTE cell monolayers
afterwarming the plates to 37°C for various periods of time.
As can be seen in Fig. 4, the presence of the Thy-l-specific
Fab' fragments globally reduced the percentage of bound
thymocytes to MTE cells but did not abolish the enhance-
ment ofcell adhesion . Fab' fragments ofThy-1-specificmAb
had a maximal inhibitory effect at the initiation of the assay.
These results support the notion that Thy-1-mediated adhe-
sion is distinct from that occurring more progressively in a
LFA-1-dependent way duringthymo-MTE cell interactions.
The nature of the ligand or receptor with which Thy-1
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